US10457938B2ActiveUtilityA9
TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
Est. expiryJun 14, 2033(~6.9 yrs left)· nominal 20-yr term from priority
C12N 15/1131C12N 2320/00C12Q 1/6886C12Q 2600/178C12N 15/113C12N 2320/10C12N 2310/141
41
PatentIndex Score
0
Cited by
21
References
3
Claims
Abstract
Described are TTV miRNAs and probes and primers comprising part of said TTV miRNA polynucleic acid. The use of said compounds for diagnosis of cancer or predisposition of cancer is also described.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A vector comprising a TTV nucleic acid operatively linked to a promoter, wherein the TTV nucleic acid consists of a nucleotide sequence selected from the group consisting of SEQ ID NOs: 1-4, 12, and 38-55.
2. A labeled primer comprising a label and an oligonucleotide of at least 15 nucleotides, wherein the oligonucleotide is comprised by a sequence selected from the group consisting of SEQ ID NOs: 38-44, 46-55, wherein the oligonucleotide comprises the nucleotide sequence CATCCYY (with Y=C or T).
3. The primer of claim 2 , wherein the nucleotide sequence CATCCYY is selected from the group consisting of CATCCCC, CATCCCT, and CATCCTC.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.